Cara Rosenbaum, MD | oneAMYLOIDOSISvoice
Healthcare Professionals

Cara Rosenbaum, MD

Healthcare Professional
Assistant Professor
Weill Cornell Medicine
1300 York Avenue
New York, New York, United States
Cara Rosenbaum is an Assistant Professor of Medicine at Weill Cornell Medical College, New York. She completed her graduation from Columbia University in New York, and MD with honors from University of Illinois College of Medicine. She then received her training in Internal Medicine at the University of Chicago, where she also completed her combined fellowship in Hematology and Medical Oncology. Dr. Rosenbaum is a hematologist, oncologist with an expertise in treating blood cancers, specifically multiple myeloma and amyloidosis. 
Dr. Rosenbaum’s areas of expertise are AL amyloidosis, monoclonal gammopathy of undetermined significance, multiple myeloma, plasma cell dyscrasia, plasma cell leukemia, poems syndrome, smoldering myeloma, stem cell transplantation, waldenstrom’s macroglobulinemia, malignant lymphoplasmacytic lymphoma and bone marrow transplantation.
At Weill Cornell Medicine, Dr. Rosenbaum treats all stages of multiple myeloma and amyloidosis including cardiac amyloidosis. She specializes in the care of complications of multiple myeloma and amyloidosis, working closely with radiation oncologists, surgeons, cardiologists and other specialists to support an integrated approach to patient care along with performing stem cell transplantation for myeloma and amyloidosis.
Dr. Rosenbaum has devoted her career to the treatment and care of patients with plasma cell dyscrasias, including multiple myeloma and amyloidosis. She is actively involved in clinical and translational research in these conditions, and has served as principle or co-investigator on numerous clinical research trials that incorporate novel therapies for her patients.
Representative Publications:


The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.